Cromakalim activates an IK(ATP)-like conductance in frog heart myocytes via an external membrane action independent of cellular ATP content.
No takes yet. Share an insight, caveat, or question.
Does not alter clinical KATP modulator use; leaves open ATP-independent activation as a target in mammalian myocardium.
Pilsudski et al. (1990) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: